NCT03518281View on ClinicalTrials.gov

Ability of a Euglena Beta Glucan Supplementation to Augment Immune Function

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 28, 2018

Primary Completion Date

September 1, 2018

Study Completion Date

December 1, 2018

Conditions
Symptoms FluSymptoms Cold
Interventions
DIETARY_SUPPLEMENT

Whole Cell Euglena containing Beta Glucan

Whole Cell Euglena containing \>50% Beta Glucan

DIETARY_SUPPLEMENT

Placebo

microcrystalline cellulose, hypromellose, titanium dioxide, water

Trial Locations (1)

N6A 5R8

KGK Science Inc., London

Sponsors

Collaborators (1)

KGK Science Inc.
All Listed Sponsors
collaborator

KGK Science Inc.

INDUSTRY

lead

Kemin Foods LC

INDUSTRY

NCT03518281 - Ability of a Euglena Beta Glucan Supplementation to Augment Immune Function | Biotech Hunter | Biotech Hunter